06/09/2025
7:05 AM | Checkpoint Therapeutics (Filer)
| Form 15-12G | |
06/04/2025
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
06/04/2025
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
06/04/2025
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
06/04/2025
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
06/04/2025
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
06/04/2025
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
06/03/2025
5:46 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
06/03/2025
5:34 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
10:14 AM | Amit Sharma (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
10:15 AM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CKPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/30/2025
10:16 AM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
10:17 AM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
10:18 AM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
10:19 AM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
10:20 AM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
10:21 AM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
10:22 AM | Checkpoint Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/30/2025
9:07 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
9:13 AM | Checkpoint Therapeutics (Filer)
| Form POS AM | |
05/30/2025
9:13 AM | Checkpoint Therapeutics (Filer)
| Form POS AM | |
05/30/2025
9:14 AM | Checkpoint Therapeutics (Filer)
| Form POS AM | |
05/30/2025
9:14 AM | Checkpoint Therapeutics (Filer)
| Form POS AM | |
05/30/2025
9:15 AM | Checkpoint Therapeutics (Filer)
| Form POS AM | |
05/30/2025
9:17 AM | Checkpoint Therapeutics (Filer)
| Form S-8 POS | |
05/30/2025
9:18 AM | Checkpoint Therapeutics (Filer)
| Form S-8 POS | |
05/30/2025
9:19 AM | Checkpoint Therapeutics (Filer)
| Form S-8 POS | |
05/30/2025
9:19 AM | Checkpoint Therapeutics (Filer)
| Form S-8 POS | |
05/30/2025
9:20 AM | Checkpoint Therapeutics (Filer)
| Form S-8 POS | |
05/30/2025
9:20 AM | Checkpoint Therapeutics (Filer)
| Form S-8 POS | |
05/29/2025
6:00 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2025
7:00 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2025
3:35 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/14/2025
4:30 PM | Checkpoint Therapeutics (Filer)
| Form PREM14A | |
04/03/2025
6:26 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
6:27 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/17/2025
4:04 PM | Beryl Capital Management LLC (Filed by)
Checkpoint Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/10/2025
4:24 PM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
03/10/2025
6:30 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
6:31 AM | Checkpoint Therapeutics (Filer)
| Form DEFA14A | |
New Rule Hits in July — The Smart Money Already Moved (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
02/27/2025
3:25 PM | Checkpoint Therapeutics (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech, Inc. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
4:38 PM | ARMISTICE CAPITAL, LLC (Filed by)
Checkpoint Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
7:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
8:00 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
4:27 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:26 PM | Checkpoint Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech, Inc. (Filed by)
| Form SCHEDULE 13D/A | |
12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
SALZMAN BARRY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:33 PM | Checkpoint Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Checkpoint Therapeutics (Issuer)
Herskowitz Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:30 PM | Bechon Christian (Reporting)
Checkpoint Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:31 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
8:32 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:00 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2024
11:15 PM | Checkpoint Therapeutics (Filer)
| Form EFFECT | |
08/19/2024
4:14 PM | Checkpoint Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/12/2024
3:40 PM | Checkpoint Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
7:45 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:05 PM | Checkpoint Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
07/03/2024
7:39 AM | Checkpoint Therapeutics (Filer)
| Form 424B5 | |
07/03/2024
7:44 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
7:00 PM | Checkpoint Therapeutics (Issuer)
GRAY WILLIAM GARRETT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
7:01 PM | Checkpoint Therapeutics (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:46 AM | Checkpoint Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy CKPT Stock Free CKPT Stock Alerts